S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14
S&P 500   3,923.68
DOW   31,490.07
QQQ   291.14

Evolent Health (EVH) Stock Forecast, Price & News

-0.71 (-2.36%)
(As of 05/18/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
895,535 shs
Average Volume
711,050 shs
Market Capitalization
$2.69 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive EVH News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

Evolent Health logo

About Evolent Health

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.


See More Headlines

Industry, Sector and Symbol

Management services
Year Founded

Sales & Book Value

Annual Sales
$907.96 million
Cash Flow
$0.87 per share
Book Value
$6.67 per share


Net Income
$-37.60 million
Pretax Margin




Free Float
Market Cap
$2.69 billion

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End


Overall MarketRank

2.33 out of 5 stars

Computer And Technology Sector

285th out of 930 stocks

Management Services Industry

5th out of 9 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Evolent Health (NYSE:EVH) Frequently Asked Questions

Is Evolent Health a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Evolent Health stock.
View analyst ratings for Evolent Health
or view top-rated stocks.

When is Evolent Health's next earnings date?

Evolent Health is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Evolent Health

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) announced its quarterly earnings data on Wednesday, May, 4th. The technology company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.20. The technology company had revenue of $297.10 million for the quarter, compared to the consensus estimate of $286.81 million. Evolent Health had a negative net margin of 3.35% and a negative trailing twelve-month return on equity of 0.86%. Evolent Health's revenue for the quarter was up 37.7% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.06) earnings per share.
View Evolent Health's earnings history

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health updated its second quarter 2022 earnings guidance on Monday, May, 16th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $290.00 million-$305.00 million, compared to the consensus revenue estimate of $285.39 million.

What price target have analysts set for EVH?

3 Wall Street analysts have issued twelve-month price objectives for Evolent Health's shares. Their forecasts range from $35.00 to $45.00. On average, they expect Evolent Health's stock price to reach $40.00 in the next year. This suggests a possible upside of 36.3% from the stock's current price.
View analysts' price targets for Evolent Health
or view top-rated stocks among Wall Street analysts.

Who are Evolent Health's key executives?
Evolent Health's management team includes the following people:
  • Mr. Frank John Williams, Co-Founder & Non-Exec. Chairman (Age 55, Pay $1.11M) (LinkedIn Profile)
  • Mr. Seth Barrie Blackley, Co-Founder, CEO & Director (Age 43, Pay $1.15M)
  • Mr. John Paul Johnson, Chief Financial Officer (Age 38, Pay $761.4k)
  • Mr. Steve Tutewohl, Chief Operating Officer (Age 49, Pay $1.09M) (LinkedIn Profile)
  • Mr. Aammaad Shams, Principal Accounting Officer & Corp. Controller (Age 38, Pay $316.23k)
  • Mr. Jonathan David Weinberg, Chief Legal Officer, Gen. Counsel & Sec. (Age 54, Pay $513.07k)
  • Mr. Seth R. Frank, VP of Investor Relations
  • Ms. Jessica Somers, Sr. VP of Corp. Devel.
  • Dr. Norman C. Payson, Advisor (Age 73)
  • Dr. John Tam M.D., Chief Strategy Officer
What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health CEO Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among Evolent Health's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Evolent Health's key competitors?
What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.43%), Engaged Capital LLC (7.80%), BlackRock Inc. (6.81%), Granahan Investment Management LLC (4.98%), Dimensional Fund Advisors LP (3.52%) and Bellevue Group AG (2.88%). Company insiders that own Evolent Health stock include Cheryl Scott, Frank J Williams, Frank J Williams, Jonathan Weinberg, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends for Evolent Health

Which major investors are selling Evolent Health stock?

EVH stock was sold by a variety of institutional investors in the last quarter, including Eagle Asset Management Inc., Engaged Capital LLC, Granahan Investment Management LLC, 13D Management LLC, Sectoral Asset Management Inc., Dimensional Fund Advisors LP, First Trust Advisors LP, and Peregrine Capital Management LLC. Company insiders that have sold Evolent Health company stock in the last year include Cheryl Scott, Frank J Williams, Jonathan Weinberg, Seth Blackley, Simon Maisey, and Steve Tutewohl.
View insider buying and selling activity for Evolent Health
or view top insider-selling stocks.

Which major investors are buying Evolent Health stock?

EVH stock was bought by a variety of institutional investors in the last quarter, including Invesco Ltd., Loomis Sayles & Co. L P, Fuller & Thaler Asset Management Inc., Rock Springs Capital Management LP, BlackRock Inc., Principal Financial Group Inc., Vanguard Group Inc., and Truist Financial Corp.
View insider buying and selling activity for Evolent Health
or or view top insider-buying stocks.

How do I buy shares of Evolent Health?

Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $29.34.

How much money does Evolent Health make?

Evolent Health has a market capitalization of $2.69 billion and generates $907.96 million in revenue each year. The technology company earns $-37.60 million in net income (profit) each year or ($0.38) on an earnings per share basis.

How many employees does Evolent Health have?

Evolent Health employs 3,500 workers across the globe.

What is Evolent Health's official website?

The official website for Evolent Health is www.evolenthealth.com.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at (571) 389-6000, via email at [email protected], or via fax at 571-389-6001.

This page was last updated on 5/19/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.